Skip to contentB
Bio Essence Corp
B
BIOEBio Essence Corp Q1 2024 · 10-Q
Revenue—
Net Income$133.94K$133.94KN/M vs Q1 2023 EPS Diluted$0.00$0.00N/M vs Q1 2023 Operating Income-$151,828N/M Operating Cash Flow-$171,613N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio Essence Corp · CIK 1723059 · Engraved from SEC EDGAR
ended Mar 31, 2024 · filed May 17, 2024 · 47 d after period end